STOCK TITAN

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
TransMedics Group, Inc. (Nasdaq: TMDX) to participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference. The chat will take place on November 28, 2023, at 2:30 p.m. Eastern Time. A live and archived webcast will be available on the company's website.
Positive
  • None.
Negative
  • None.

ANDOVER, Mass., Nov. 14, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 28, 2023, at 2:30 p.m. Eastern Time.

Event: Piper Sandler 35th Annual Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 2:30 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-piper-sandler-35th-annual-healthcare-conference-301988157.html

SOURCE TransMedics Group, Inc.

FAQ

What is TransMedics Group, Inc. participating in?

TransMedics Group, Inc. is participating in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference.

When will the fireside chat take place?

The fireside chat will take place on Tuesday, November 28, 2023, at 2:30 p.m. Eastern Time.

Where can I watch the webcast of the fireside chat?

A live and archived webcast of the fireside chat will be available on the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

4.09B
31.55M
3.62%
111.73%
18.31%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ANDOVER

About TMDX

transmedics inc. is the world’s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. the company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. the ocs™ lung and ocs™ heart systems are ce-marked and in commercial use outside the us, and are currently being reviewed by the fda for u.s. market access. the ocs™ liver is in an fda pivotal trial (the ocs™ liver protect trial) in the united states and a ce-mark trial in (the revive trial) in europe.